Matthew C Pickering Selected Research

Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)

1/2022	Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis.
1/2019	C3 glomerulopathy - understanding a rare complement-driven renal disease.
5/2015	Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation.
4/2014	A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry.
1/2014	C3 glomerulopathy: clinicopathologic features and predictors of outcome.
11/2013	Dense deposit disease and C3 glomerulopathy.
7/2013	Recent insights into C3 glomerulopathy.
11/2011	Regulating complement in the kidney: insights from CFHR5 nephropathy.
8/2011	Dense deposit disease.
1/2011	Experimental models of membranoproliferative glomerulonephritis, including dense deposit disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew C Pickering Research Topics

Disease

16	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022 - 08/2002
16	Glomerulonephritis 01/2021 - 06/2009
15	Inflammation (Inflammations) 10/2021 - 01/2005
10	Kidney Diseases (Kidney Disease) 01/2022 - 11/2011
9	IGA Glomerulonephritis (IGA Nephropathy) 10/2021 - 07/2012
8	Atypical Hemolytic Uremic Syndrome 01/2019 - 08/2010
7	Infections 01/2021 - 01/2012
6	COVID-19 11/2021 - 01/2020
6	Macular Degeneration (Age-Related Maculopathy) 11/2021 - 10/2007
6	Complement Factor H Deficiency 01/2021 - 10/2007
6	Lupus Nephritis 01/2020 - 01/2010
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2021 - 01/2010
4	Renal Insufficiency (Renal Failure) 11/2021 - 09/2010
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 08/2011
2	Disease Susceptibility (Diathesis) 01/2022 - 11/2021
2	Chronic Renal Insufficiency 01/2022 - 01/2021
2	Hemolysis 01/2020 - 01/2019
2	Thrombotic Microangiopathies 01/2019 - 01/2011
2	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 07/2011
2	Ischemia 01/2018 - 07/2011
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 11/2016
2	Blindness (Hysterical Blindness) 01/2017 - 10/2007
2	Proteinuria 09/2015 - 09/2007
2	Meningococcal Infections 12/2014 - 03/2014
2	Cicatrix (Scar) 01/2014 - 01/2005
2	Arthritis (Polyarthritis) 12/2013 - 04/2013
2	Meningitis 03/2013 - 01/2012
2	Rare Diseases (Rare Disease) 08/2011 - 09/2007
1	Asymptomatic Diseases 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Necrosis 01/2020
1	Neoplasms (Cancer) 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Bacterial Meningitis 12/2019
1	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 12/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Splenomegaly 01/2019
1	Hematuria 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Rhabdomyolysis 04/2018
1	Muscular Diseases (Myopathy) 04/2018
1	Myalgia 04/2018
1	Muscle Weakness 04/2018
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 12/2017
1	Rheumatic Diseases (Rheumatism) 09/2017

Drug/Important Bio-Agent (IBA)

42	Complement System Proteins (Complement)IBA 01/2022 - 02/2009
30	Complement Factor H (Factor H)IBA 01/2021 - 08/2002
19	Proteins (Proteins, Gene)FDA Link 11/2021 - 06/2009
8	Complement C3 (C3 Complement)IBA 01/2022 - 10/2009
8	AntibodiesIBA 01/2021 - 01/2010
7	Dichlorodiphenyldichloroethane (DDD)IBA 01/2019 - 09/2007
4	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2011
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2012
3	Antigen-Antibody Complex (Immune Complex)IBA 11/2021 - 01/2005
3	Immunoglobulin A (IgA)IBA 10/2021 - 10/2019
3	Retinaldehyde (Retinal)IBA 08/2013 - 10/2007
2	Immunoglobulin G (IgG)IBA 11/2021 - 01/2021
2	LectinsIBA 10/2021 - 01/2021
2	CollagenIBA 01/2020 - 04/2013
2	Messenger RNA (mRNA)IBA 01/2020 - 06/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2018
2	Immunoglobulin M (IgM)IBA 01/2018 - 09/2015
2	eculizumab FDA Link 12/2015 - 09/2007
2	VaccinesIBA 03/2014 - 01/2012
2	Fibrinogen (Factor I)FDA Link 01/2011 - 02/2008
1	factor H-related protein 1IBA 01/2022
1	Pharmaceutical PreparationsIBA 11/2021
1	Complement Inactivating AgentsIBA 10/2021
1	Complement C3-C5 Convertases (C3 Convertase)IBA 01/2021
1	inter-alpha-inhibitorIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 01/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2021
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	ProperdinIBA 01/2021
1	Interferon Type IIBA 01/2021
1	AntithrombinsIBA 01/2021
1	human CFH proteinIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Heme (Haem)IBA 01/2020
1	phenylhydrazine (phenylhydrazine hydrochloride)IBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	AutoantibodiesIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2019
1	CreatinineIBA 01/2019
1	Creatine Kinase (Creatine Phosphokinase)IBA 04/2018
1	Serine (L-Serine)FDA Link 03/2018
1	galactosyl-deficient IgA1IBA 03/2018
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 03/2018
1	EpitopesIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Prion ProteinsIBA 12/2017

Therapy/Procedure

7	Therapeutics 11/2021 - 08/2010
2	Renal Dialysis (Hemodialysis) 01/2021 - 01/2020
2	Kidney Transplantation 01/2020 - 11/2013
1	Drug Therapy (Chemotherapy) 01/2020